Cargando…
Concurrent immunotherapy and re‐irradiation utilizing stereotactic body radiotherapy for recurrent high‐grade gliomas
BACKGROUND: Clinical trials evaluating immune checkpoint inhibition (ICI) in recurrent high‐grade gliomas (rHGG) report 7%–20% 6‐month progression‐free survival (PFS), while re‐irradiation demonstrates 28%–39% 6‐month PFS. AIMS: We evaluate outcomes of patients treated with ICI and concurrent re‐irr...
Autores principales: | Mahase, Sean S., Roytman, Michelle, Roth O'Brien, Diana, Ivanidze, Jana, Schwartz, Theodore H., Pannullo, Susan C., Ramakrishna, Rohan, Magge, Rajiv S., Williams, Nicholas, Fine, Howard A., Chiang, Gloria Chia‐Yi, Knisely, Jonathan P. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363830/ https://www.ncbi.nlm.nih.gov/pubmed/36750401 http://dx.doi.org/10.1002/cnr2.1788 |
Ejemplares similares
-
43. DELAYS IN ADJUVANT STEREOTACTIC RADIOSURGERY REDUCE LOCAL CONTROL FOR RESECTED BRAIN METASTASES
por: Roth O’Brien, Diana, et al.
Publicado: (2020) -
45. DELAY OR FAILURE TO ADMINISTER STEREOTACTIC RADIOSURGERY TO THE CAVITY AFTER SURGERY FOR BRAIN METASTASES. AN INTENTION-TO-TREAT ANALYSIS
por: O’Brien, Diana Roth, et al.
Publicado: (2020) -
327 Radiopathomics: Integration of Advanced Neuroimaging and Molecular Pathology Features in Meningiomas
por: Haghdel, Arsalan, et al.
Publicado: (2023) -
Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical center
por: Pan, Peter C, et al.
Publicado: (2021) -
Evaluating diagnostic accuracy and determining optimal diagnostic thresholds of different approaches to [(68)Ga]-DOTATATE PET/MRI analysis in patients with meningioma
por: Kim, Sean H., et al.
Publicado: (2022)